主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TXG
#1442
10x Genomics, Inc. Class A Common Stock
23.050
0
+15.37%
版块:
基础:
利润货币:
日范围
年范围
日变化
+15.37%
每月变动
+6.71%
6个月变化
+66.79%
年变化
+66.79%
前一天收盘价
19.980
0
Open
23.050
0
Bid
Ask
Low
23.050
0
High
23.050
0
交易量
221
市场
股票
医疗保健
TXG
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
121.05 M
122.3 M
123.13 M
124.49 M
126.55 M
127.75 M
—
Valuation ratios
Enterprise value
2.34 B
1.41 B
697.9 M
1.04 B
1.05 B
1.61 B
4.4 B
Price to earnings ratio
-14.66
-9.45
-6.72
-16.54
-18.85
-46.6
-88.71
Price to sales ratio
4.27
2.83
1.69
2.19
2.24
3.17
9.29
Price to cash flow ratio
-209.77
259.56
42.66
28.29
16.45
14.96
102.35
Price to book ratio
0.93
2.44
0.37
0.49
0.48
2.56
3.89
Enterprise value to EBITDA ratio
-14.32
-8.9
-5.07
-15.59
-18.56
-64.94
-104.16
Profitability ratios
Return on assets %
0.04
0.05
0.04
0.04
0.03
-0.05
0.05
Return on equity %
0.05
0.07
0.05
0.04
0.03
-0.07
0.06
Return on invested capital %
34.02
43.2
35.06
25.25
26.74
-35.49
51.56
Gross margin %
70.16
67.24
68.08
72.34
67.32
68.09
275.83
Operating margin %
27.36
30.2
25.39
17.42
21.64
-24.52
39.93
EBITDA margin %
-21.44
-24.9
-20.21
21.94
-14.73
-5.71
-18.71
Net margin %
23.58
29.71
22.18
19.97
18.44
-31.82
28.78
Liquidity ratios
Quick ratio
4.12
4.26
4.68
5.23
4.06
4.09
18.06
Current ratio
4.9
4.97
5.37
5.84
4.48
4.46
20.15
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.16
0.18
0.17
0.18
0.15
0.16
0.66
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.04
-0.06
0.28
0.14
0.34
0.33
1.09
EBIT per share
-0.34
-0.41
-0.32
0.24
-0.26
-0.16
-0.49
EBITDA per share
-0.27
-0.34
-0.26
0.3
-0.17
-0.08
-0.2
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.3
3.27
3.48
3.59
3.84
4.2
15.11
Net current asset value per share
4.92
4.85
4.73
5.27
5.26
5.49
20.74
Tangible book value per share
5.82
5.73
5.6
6.06
5.7
5.85
23.21
Working capital per share
3.91
3.88
3.85
4.36
4.08
4.26
16.55
Book value per share
5.99
5.9
5.77
6.21
6.26
6.38
24.62
10x Genomics Inc
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
新闻
Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%
加拿大股市上涨;截至收盘加拿大多伦多S&P/TSX 综合指数上涨0.61%
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
Priceline, Carvana, DoorDash and more set to report earnings Wednesday
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Canaccord Genuity上调10X Genomics目标价至22美元,此前为20美元
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity
Applied Materials and Rivian among market cap stock movers on Friday
Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics
10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates
10X Genomics面临新定价策略首次亮相的盈利考验
10X Genomics faces earnings test as new pricing strategy debuts